In a recent revelation, a United Nations report underscores a troubling trend in Afghanistan’s illicit drug landscape. While the Taliban regime, which reclaimed power in August 2021, imposed a ban in April on narcotics production in Afghanistan, traditionally the world’s foremost opium producer, a remarkable shift has occurred. Methamphetamine trafficking has seen a dramatic upswing in the region, demanding urgent international attention, according to Ghada Waly, the Executive Director of the United Nations Office of Drugs and Crime (UNODC).
Notably, the UNODC observes that as heroin trafficking has declined, methamphetamine trafficking has intensified since the ban was enacted. Over the span of five years leading up to 2021, meth seizures in and around Afghanistan have skyrocketed by a staggering twelvefold. Furthermore, neighboring countries such as Iran and Pakistan have reported escalating methamphetamine seizures between 2019 and 2022. Astonishingly, methamphetamine suspected to originate from Afghanistan has even surfaced in countries as distant as France and Australia.
The UNODC’s report sheds light on the predominant source of methamphetamine production in Afghanistan, revealing that precursor ingredients akin to those found in certain cold and flu medications are commonly employed. Although Afghanistan possesses the ephedra plant, a vital component in methamphetamine synthesis, the UNODC elucidates that the drug’s production doesn’t hinge solely on this plant due to the substantial quantities required and the inherent risk associated with unreliable crop yields. Instead, the UNODC underscores the efficiency and cost-effectiveness of employing common cold medications and industrial-grade chemicals in the manufacture of methamphetamine, thereby posing a more significant and daunting threat.
Reuters
